For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on February 4th, 2026 | 08:50 CET
Yesterday +10%! Top news drives shares of Evotec, Novo Nordisk, and CHAR Technologies!
Evotec shares jumped, climbing more than 10% as analysts pushed the stock higher. Does this signal that the turnaround is finally happening, or does Deutsche Bank still have the final say? Strong news also for CHAR Technologies: the Canadian company is launching commercialization of its unique technology for producing biochar and renewable natural gas substitutes from biogenic waste materials. For the expansion, it has secured strong partners, including steel giant ArcelorMittal and the Canadian BMI Group. And what is Novo Nordisk doing? The Danish company presented positive study results for its successor to Wegovy. However, analysts are not exactly thrilled.
Read
Commented by Fabian Lorenz on February 4th, 2026 | 07:35 CET
DISAPPOINTMENT at Puma! RENK "Top Pick" or "Hold"? RE Royalties awakens!
We have repeatedly pointed to RE Royalties as an AI beneficiary and dividend gem. The stock has finally been gaining momentum for several weeks now. Nevertheless, the dividend yield is over 10%, and the company plans to continue to push ahead with electricity and energy storage for the AI boom. This suggests that prices will continue to rise. Puma's share price, on the other hand, has been disappointing. The new major shareholder paid EUR 35 per share, but the price on the stock market is below EUR 24. Analysts currently see no upside potential. A takeover could take place in 15 months at the earliest. This means that Puma's operational issues remain in focus. Analysts are divided on RENK. For some, the group is the "Top Pick" in the defense sector. For others, it is merely a "Hold" position.
Read
Commented by Fabian Lorenz on February 3rd, 2026 | 07:15 CET
US government pours billions into USA Rare Earth - Could Antimony Resources be next?
Almonty Industries, MP Materials, and other commodity stocks have already demonstrated the new reality: in today's geopolitical environment, commodities are becoming critical, and stock prices can multiply dramatically. Antimony Resources offers investors an opportunity to participate at a comparatively early stage. History shows that when mining companies transition from explorer to producer, valuations can move into the billions. Despite a strong rally, Antimony Resources is still valued at "only" around EUR 50 million. Due to pressure from the US government and a mining-friendly jurisdiction, Antimony Resources could advance toward production significantly faster than is typical in the sector. A direct involvement by the US government would not be surprising. After investments in MP Materials, Vulcan Elements, and Trilogy Metals, the Trump administration recently pumped billions into USA Rare Earth. Could Antimony Resources be next?
Read
Commented by Fabian Lorenz on February 2nd, 2026 | 07:45 CET
Plug Power under pressure! 2G Energy and the AI BOOM! 100% PRICE POTENTIAL for A.H.T. Syngas shares!
Analysts see over 100% upside potential for A.H.T. Syngas shares. Experts believe the company is on the verge of a growth spurt. The market potential for synthetic natural gas substitutes from biogenic residues is huge. In addition, the company is in the process of transforming itself from a pure plant manufacturer to an energy producer. While A.H.T. is only worth around EUR 10 million on the stock market, 2G Energy is already worth EUR 600 million. This is also raising shareholders' expectations. The latest order intake failed to provide any impetus, with everyone waiting for news from the US. There is currently a sense of alarm at Plug Power in the US. At an extraordinary general meeting, shareholders are to decide on the future of the hydrogen specialist. The postponement of the event is causing uncertainty.
Read
Commented by Fabian Lorenz on January 30th, 2026 | 09:00 CET
DroneShield disappoints! Plug Power fights for survival! American Atomics stock poised for an overdue rally?!
Tech analyst Pip Klöckner paints a clear picture for 2026: he expects NVIDIA CEO Jensen Huang to become the world's most influential energy lobbyist. Without additional, reliable energy, data centers cannot operate - and without data centers, no one will buy NVIDIA chips. Meta is already fully committed to nuclear energy, underlining how critical stable baseload power has become in the AI race. American Atomics stands to benefit from this development. After all, uranium is needed regardless of who builds the nuclear power plants or ultimately wins the AI arms race. Importantly, American Atomics is developing several promising projects directly in the United States. The AI-driven energy boom has also lifted hydrogen stocks in the past, including Plug Power, but the euphoria has faded, and the Copmany is now fighting for survival. And what about DroneShield? The drone defense specialist's shares have taken a sharp hit in recent days. Was the sell-off triggered by the latest quarterly figures, or is something else at play?
Read
Commented by Fabian Lorenz on January 29th, 2026 | 07:00 CET
Puma takeover is becoming more concrete! Should investors buy Evotec and Silver Viper shares next?
Takeover speculation has been swirling around Puma for some time. Now it has become more tangible: Anta has secured a 29% stake in the German sporting goods group, paying EUR 35 per share. However, the euphoria on the stock market is limited. Are there better opportunities for investors to profit from takeover speculation? One candidate in the hot silver market is Silver Viper. The Company is pushing ahead with exciting projects in Mexico. Its recent capital increase met with strong demand, and a financially powerful potential buyer already has a foot in the door. And what about Evotec? The perennial takeover candidate is still not gaining momentum. That said, the biotech company is benefiting from the sale of one of its own holdings, which is expected to bring in around USD 160 million.
Read
Commented by Fabian Lorenz on January 28th, 2026 | 07:10 CET
PRICE EUPHORIA at OHB! Rheinmetall takes on Airbus and Elon Musk? D-Wave completes acquisition! Finexity shares take off!
Could Rheinmetall, together with OHB, soon challenge Elon Musk's Starlink and Airbus? At any rate, OHB's share price reacted with a jump of more than 50%. Finexity shares have also surged. Following its pilot project with a savings bank, the Company has brought another exciting partner on board for its marketplace for tokenized assets. The price jump is likely to be just the beginning, as the market capitalization remains low. By contrast, D-Wave shares are showing no signs of slowing down. The Company has successfully completed an important acquisition, which is expected to be a milestone in strengthening its leading position in the quantum computing space.
Read
Commented by Fabian Lorenz on January 27th, 2026 | 07:15 CET
Silver is unstoppable! Defense stocks in demand! Steyr Motors, Deutz, and Silver North Resources in focus
Silver is currently breaking all records and even eclipsing its big brother, gold. Yesterday, the price of silver climbed to over USD 108. And for good reason: the precious metal is not only a crisis currency, but is increasingly becoming a "critical commodity." Investors who want to profit should not only look at the basic investments, but also at the second-tier winners. In the case of silver, this is Silver North Resources. The explorer's two projects in Canada are so convincing to investors that the current capital increase has been topped up, and the Company is fully financed for two years. The stock now offers an entry opportunity. Steyr Motors shares are also back in the fast lane. A framework agreement with minimum purchase quantities from Asia is providing new momentum. Deutz shares are close to their all-time high. Both engine manufacturers are benefiting from the defense boom.
Read
Commented by Fabian Lorenz on January 26th, 2026 | 07:15 CET
Record highs for gold, silver, and copper! But tungsten is really taking off! Almonty shares are eclipsing Barrick Mining and MP Materials!
Commodity prices are running wild. But anyone who thinks that developments in gold and silver are record-breaking should take a look at tungsten. It is increasingly becoming the number one critical metal. Within a year, the price has surged from just over USD 300 to more than USD 1,200. Almonty Industries is benefiting from this. Almonty Industries is benefiting from this. From the perspective of CEO Lewis Black, however, the price itself is not the decisive factor, but something else entirely. Although tungsten is increasingly emerging from the shadow of rare earths, it is still the rare earths that dominate the headlines. MP Materials has both the US government and Apple on board, and analysts continue to see outperformance. Barrick Mining should also be making a fortune at the moment. Not only is gold at record levels, but copper is too.
Read
Commented by Fabian Lorenz on January 26th, 2026 | 01:35 CET
BASF under PRESSURE! BUY RECOMMENDATIONS for BioNTech and WashTec shares!
Market leadership, increased efficiency, dividends, and share buybacks - all good reasons to buy WashTec shares. Analysts at M.M. Warburg share this assessment. Their earnings estimates for the coming years may even be too conservative. Unfortunately, nothing about BASF is conservative; rather, it is disappointing. The chemical company has once again failed to meet analysts' forecasts. Its strong free cash flow is based on lower investments, which is also not a good sign. How are analysts reacting? BioNTech is facing a groundbreaking year. Analysts see potential for share price growth. News from the bulging product pipeline is likely to have a significant impact on the share price.
Read